VANGUARD GROUP INC 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-30 2:04 pm Purchase | 2025-09-30 | 13G | 10x Genomics, Inc. TXG | VANGUARD GROUP INC | 13,274,332 11.600% | 2,301,402 (+20.97%) | Filing |
| 2024-10-04 2:14 pm Purchase | 2024-09-30 | 13G | 10x Genomics, Inc. TXG | VANGUARD GROUP INC | 10,972,930 10.300% | 1,961,598 (+21.77%) | Filing |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | 10x Genomics, Inc. TXG | VANGUARD GROUP INC | 9,011,332 8.650% | 591,321 (+7.02%) | Filing |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | 10x Genomics, Inc. TXG | VANGUARD GROUP INC | 8,420,011 8.810% | 865,969 (+11.46%) | Filing |
| 2022-02-09 3:15 pm Purchase | 2021-12-31 | 13G | 10x Genomics, Inc. TXG | VANGUARD GROUP INC | 7,554,042 8.250% | 1,366,337 (+22.08%) | Filing |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | VANGUARD GROUP INC | 6,187,705 7.720% | 6,187,705 (New Position) | Filing |